About Steve Greenberg, MD, PhD
Dr. Steven M. Greenberg, Professor of Neurology at Harvard Medical School, holds the John J. Conway Endowed Chair in Neurology, directs the Hemorrhagic Stroke Research Program, and is Vice-Chair for Faculty Development and Promotions at the Massachusetts General Hospital. Dr. Greenberg has authored over 350 research articles and 100 chapters, reviews, and editorials in the areas of hemorrhagic stroke and small vessel brain disease. He has served in many national and international leadership roles including Co-Chair of the American Heart Association ARIA Summit, Principal Investigator for the NINDS MarkVCID biomarkers consortium coordinating center, Co-Principal Investigator for the NINDS DISCOVERY network on post-stroke cognition, Chair of the International CAA Association, Chair of the 2022 American Heart Association Guidelines for Management of Spontaneous Intracerebral Hemorrhage Writing Group, and chair of the American Heart Association International Stroke Conference. Dr. Greenberg is a recipient of the 2024 Harvard Medical School William Silen Lifetime Achievement in Mentoring Award and the 2017 American Heart Association Feinberg Award for Excellence in Clinical Stroke.
Clinical Interests:
- Cerebral hemorrhage
- Dementia
- Stroke
Treats:
- Adult
Locations
Mass General Vascular Center: Stroke Service
55 Fruit St.
Wang Ambulatory Care Center
7th Floor, Suite 720
Boston, MA 02114
Phone: 617-726-8459
Medical Education
- MD, Columbia University College of Physicians & Surgeons
- Residency, Massachusetts General Hospital
- Fellowship, Brigham and Women's Hospital
American Board Certifications
- Neurology, American Board of Psychiatry & Neurology
- Vascular Neurology, American Board of Psychiatry & Neurology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Greenberg has authored over 140 research articles and 60 chapters, reviews, and editorials in the areas of hemorrhagic stroke and small vessel brain disease, served as principal investigator on multiple national research grants, and in leadership positions at national and international conferences on hemorrhagic stroke and vascular cognitive impairment. He is currently Chair of the American Heart Association International Stroke Conference, Session Co-Chair of the NINDS Alzheimer's Disease-Related Dementias Workshop, and charter member of the NIH Acute Neural Injury and Epilepsy study section.
Publications
-
Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, van Buchem MA, Bruckmann H, Greenberg SM. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010;74:1346-1350.
Greenberg SM, Nandigam RNK, Delgado P, Betensky RA, Rosand J, Viswanathan A, Frosch MP, Smith EE. Microbleeds versus macrobleeds: Evidence for distinct entities. Stroke 2009;40:2382-6.
Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, Greenberg SM. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009;72:1230-1235.
Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CRG, Greenberg SM. Spatial distribution of white matter hyperintensities in Alzheimers disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008;39:1127-1133.
Greenberg SM, Grabowski TJ, Gurol ME, Skehan ME, Nandigam RNK, Becker JA, Garcia-Alloza M, Prada C, Frosch MP, Rosand J, Viswanathan A, Smith EE, Johnson KA. Detection of isolated cerebrovascular ß-amyloid with Pittsburgh compound B. Ann Neurol 2008;64:587-591.